Hypoxia-inducible factor-1α dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1151-1166

  An, Yu ^a,b   Zhang, Jian Zhao ^a,b   Han, Jing ^a,b   Yang, Hao Peng ^a,b   Tie, Lu ^a,b   Yang, Xiao Yuan ^b   Xiaokaiti, Yilixiati ^a,b   Pan, Yan ^a,b   Li, Xue Jun ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Acetazolamide; Acute kidney injury; Hypoxia inducible factor 1 ; Ischemia reperfusion; Kidney transplantation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACETAZOLAMIDE; CASPASE; CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN KINASE B;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

ACETAZOLAMIDE; ANIMALS; APOPTOSIS; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RENAL CIRCULATION; REPERFUSION INJURY;

EID: 84890742631     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354515     Document Type: Article

References (54)

1. Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 2012;380:756-766.
2. Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int 2007;72:208-212.
3. Waikar SS, Liu KD, Chertow GM: Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008;3:844-861.
4. Bagshaw SM, George C, Bellomo R: Early acute kidney injury and sepsis: A multicentre evaluation. Crit Care 2008;12:R47.
5. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Spectrum of acute renal failure in the intensive care unit: The picard experience. Kidney Int 2004;66:1613-1621.
6. Munshi R, Hsu C, Himmelfarb J: Advances in understanding ischemic acute kidney injury. BMC Med 2011;9:11.
7. Snoeijs MG, van Heurn LW, Buurman WA: Biological modulation of renal ischemia-reperfusion injury. Curr Opin Organ Transplant 2010;15:190-199.
8. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR: Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009;24:1039-1047.
9. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011;121:4210-4221.
10. Semenza GL: Oxygen sensing, homeostasis, and disease. N Engl J Med 2011;365:537-547.
11. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC: Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007;27:6320-6332.
12. Adluri RS, Thirunavukkarasu M, Dunna NR, Zhan L, Oriowo B, Takeda K, Sanchez JA, Otani H, Maulik G, Fong GH, Maulik N: Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (phd-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-lalpha transcription factor and its target genes in mice. Antioxid Redox Signal 2011;15:1789-1797.
13. Guo JY, Yang T, Sun XG, Zhou NY, Li FS, Long D, Lin T, Li PY, Feng L: Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through akt-enos-no-hif pathway. J Biomed Sci 2011;18:79.
14. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Campean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: Hif activation protects from acute kidney injury. J Am Soc Nephrol 2008;19:486-494.
15. Horita Y, Yakabe K, Tadokoro M, Suyama N, Hayashida K, Kawano Y, Miyazaki M, Kohno S, Taura K: Renal circulatory effects of acetazolamide in patients with essential hypertension. Am J Hypertens 2006;19:282-285.
16. Assadi F: Acetazolamide for prevention of contrast-induced nephropathy: A new use for an old drug. Pediatr Cardiol 2006;27:238-242.
17. Kassamali R, Sica DA: Acetazolamide: A forgotten diuretic agent. Cardiol Rev 2011;19:276-278.
18. Taki K, Oogushi K, Hirahara K, Gai X, Nagashima F, Tozuka K: Preferential acetazolamide-induced vasodilation based on vessel size and organ: Confirmation of peripheral vasodilation with use of colored microspheres. Angiology 2001;52:483-488.
19. Park SW, Kim M, D'Agati VD, Lee HT: Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int 2011;80:1315-1327.
20. Silva RC, Landgraf MA, Correa-Costa M, Semedo P, Cenedeze MA, Pacheco-Silva A, Landgraf RG, Cámara NO: Acute kidney injury reduces phagocytic and microbicidal capacities of alveolar macrophages. Cell Physiol Biochem 2013;31:179-188.
21. Brooks C, Wei Q, Cho SG, Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009;119:1275-1285.
22. Wei Q, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z: Targeted deletion of dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2010;21:756-761.
23. Tie L, Yang HQ, An Y, Liu SQ, Han J, Xu Y, Hu M, Li WD, Chen AF, Lin ZB, Li XJ: Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cell Physiol Biochem 2012;29:583-594.
24. Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, Ohkita M, Matsumura Y: Protective effect of 17beta-estradiol on ischemic acute renal failure through the pi3k/akt/enos pathway. Kidney Int 2008;73:308-317.
25. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 2011;80:29-40.
26. Haase VH: The vhl/hif oxygen-sensing pathway and its relevance to kidney disease. Kidney Int 2006;69:1302-1307.
27. Gunaratnam L, Bonventre JV: Hif in kidney disease and development. J Am Soc Nephrol 2009;20:1877-1887.
28. Ke Q, Costa M: Hypoxia-inducible factor-1 (hif-1). Mol Pharmacol 2006;70:1469-1480.
29. Coulet F, Nadaud S, Agrapart M, Soubrier F: Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003;278:46230-46240.
30. Oh SW, Ahn JM, Lee YM, Kim S, Chin HJ, Chae DW, Na KY: Activation of hypoxia-inducible factor by cobalt is associated with the attenuation of tissue injury and apoptosis in cyclosporine-induced nephropathy Tohoku J Exp Med 2012;226:197-206.
31. Yu HJ, Chien CT, Lai YJ, Lai MK, Chen CF, Levin RM, Hsu SM: Hypoxia preconditioning attenuates bladder overdistension-induced oxidative injury by up-regulation of bcl-2 in the rat. J Physiol 2004;554:815-828.
32. Lim JH, Lee ES, You HJ, Lee JW, Park JW, Chun YS: Ras-dependent induction of hif-lalpha785 via the raf/ mek/erk pathway: A novel mechanism of ras-mediated tumor promotion. Oncogene 2004;23:9427-9431.
33. Li J, Davidson G, Huang Y, Jiang BH, Shi X, Costa M, Huang C: Nickel compounds act through phosphatidylinositol-3-kinase/akt-dependent, p70(s6k)-independent pathway to induce hypoxia inducible factor transactivation and cap43 expression in mouse epidermal cl41 cells. Cancer Res 2004;64:94-101.
34. Chen J, Chen JK, Harris RC: Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int 2012;82:45-52.
35. Martin RK: Acute kidney injury: Advances in definition, pathophysiology and diagnosis. AACN Adv Crit Care 2010;21:350-356.
36. Pakfetrat M, Nikoo MH, Malekmakan L, Tabandeh M, Roozbeh J, Nasab MH, Ostovan MA, Salari S, Kafi M, Vaziri NM, Adl F, Hosseini M, Khajehdehi P: A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: A randomized, double-blind trial. Int Urol Nephrol 2009;41:629-634.
37. Rosenberger C, Rosen S, Shina A, Bernhardt W, Wiesener MS, Frei U, Eckardt KU, Heyman SN: Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int 2006;70:60-70.
38. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH: Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008;19:39-46.
39. Yang CC, Lin LC, Wu MS, Chien CT, Lai MK: Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating hif-1 alpha-dependent bcl-2 signaling. Transplantation 2009;88:1251-1260.
40. Knudsen AR, Kannerup AS, Gronbaek H, Andersen KJ, Funch-Jensen P, Frystyk J, Flyvbjerg A, Mortensen FV: Effects of ischemic pre-and postconditioning on hif-lalpha, vegf and tgf-beta expression after warm ischemia and reperfusion in the rat liver. Comp Hepatol 2011;10:3.
41. Cursio R, Miele C, Filippa N, Van Obberghen E, Gugenheim J: Liver hif-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. Transplant Proc 2008;40:2042-2045.
42. Teppema LJ, Bijl H, Romberg RR, Dahan A: Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol 2006;572:849-856.
43. Iida H, Nakagawara J, Hayashida K, Fukushima K, Watabe H, Koshino K, Zeniya T, Eberl S: Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative spect reconstruction program and split-dose 123i-iodoamphetamine. J Nucl Med 2010;51:1624-1631.
44. Tuettenberg J, Heimann A, Kempski O: Nitric oxide modulates cerebral blood flow stimulation by acetazolamide in the rat cortex: A laser doppler scanning study. Neurosci Lett 2001;315:65-68.
45. Kiss B, Dallinger S, Findl O, Rainer G, Eichler HG, Schmetterer L: Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide. Am J Physiol 1999;276:R1661-1667.
46. Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S: Hif activation by ph-dependent nucleolar sequestration of vhl. Nat Cell Biol 2004;6:642-647.
47. Willam C, Warnecke C, Schefold JC, Kugler J, Koehne P, Frei U, Wiesener M, Eckardt KU: Inconsistent effects of acidosis on hif-alpha protein and its target genes. Pflugers Arch 2006;451:534-543.
48. Sporn A, Scothorn DM, Terry JE: Metabolic acidosis induced by acetazolamide. J Am Optom Assoc 1991;62:934-937.
49. Xu J, Peng Z, Li R, Dou T, Xu W, Gu G, Liu Y, Kang Z, Tao H, Zhang JH, Ostrowski RP, Lu J, Sun X: Normoxic induction of cerebral hif-lalpha by acetazolamide in rats: Role of acidosis. Neurosci Lett 2009;451:274-278.
50. Flagg SC, Martin CB, Taabazuing CY, Holmes BE, Knapp MJ: Screening chelating inhibitors of hif-prolyl hydroxylase domain 2 (phd2) and factor inhibiting hif (fih). J Inorg Biochem 2012;113:25-30.
51. Harten SK, Ashcroft M, Maxwell PH: Prolyl hydroxylase domain inhibitors: A route to hif activation and neuroprotection. Antioxid Redox Signal 2010;12:459-480.
52. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schodel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU: Donor treatment with a phd-inhibitor activating hifs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sei U S A 2009;106:21276-21281.
53. Paisley KE, Tomson CR: Calcium phosphate stones during long-term acetazolamide treatment for epilepsy Postgrad Med J 1999;75:427-428.
54. Betten DP, Bridger DJ, Felton BM: Profound alkalemia secondary to gastric outlet obstruction and acute renal insufficiency. Am J Emerg Med 2013;31:444.el-3.